Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 72789-073

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 72789-073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789073 Label (72789073)

This is a medication containing Cyclobenzaprine Hydrochloride in the form of tablets. The usual adult dosage is one tablet of 5mg taken three times a day, although detailed dosage recommendations can be found in the package outsert. The medicine must be stored in a well-closed container as defined in the USP with child-resistant closure and kept at a controlled room temperature between 20°C and 25°C. The medication is available in a pack of 30 tablets, manufactured and packaged by PD-Rx Pharmaceuticals, Inc, located in Oklahoma City. The manufacturing of the medication is carried out by Prinston Laboratories located in Charlotte. The global trade item number of the medication is 00372789073309, with a serial number of E21F19000115. The medication's expiry date is May 2023, and it should be kept out of children's reach.*

FDA Label Image

Structural Formula For Cyclobenzaprine. (Cyclobenzaprine 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.